Drugs / Revamilast
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01436890 | Oct 2011 → Apr 2013 | asthma | Glenmark Pharmaceuticals Ltd. India | Completed | No outcome recorded |
| Phase 2 | NCT01430507 | Sep 2011 → Dec 2012 | rheumatoid arthritis | Glenmark Pharmaceuticals Ltd. India | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Revamilast | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01430507 ↗ |
| Modality | Small molecule | — CHEMBL4297527 ↗ |